732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster III

The impact of additional cytogenetic abnormalities and complex karyotype on outcomes of adult patients with Philadelphia-positive acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in first complete remission

MO TRANS update A randomized double blind placebo controlled multi center phase III study of mocravimod MOC as maintenance treatment in AML patients undergoing allogeneic hematopoietic cell transplantation

Novel machine learning ML and traditional statistical techniques in survival analysis of real world data for allogeneic hematopoietic cell transplantation HCT consolidation in patients with acute lymphoblastic leukemia ALL

Improved outcomes following allogeneic hematopoietic stem cell transplantation in patients with DDX41 mutated myeloid neoplasms A prospective analysis of survival GVHD and transplant related mortality

IDH2 R172 mutation is associated with improved survival in IDH mutated AML MDS patients undergoing allogeneic stem cell transplantation A geth TC multicenter study

Comparison of autologous HCT versus haploidentical donor HCT for Ph B ALL patients following TKI therapy a study from the global committee and the acute leukemia working party of the european society for blood and marrow transplantation

The efficacy of short course blinatumomab immunotherapy as a bridge to HSCT in ph negative B cell acute lymphoblastic leukemia

Pre transplant CAR T cell therapy is associated with inferior survival and increased non relapse mortality in pediatric B ALL A single center retrospective analysis

Allogeneic hematopoietic stem cell transplantation outcomes in pediatric acute lymphoblastic leukemia A multicenter analysis from the cccg ALL 2015 protocol

Molecular stratification of relapse risk post allogeneic hematopoietic stem cell transplantation in myeloid neoplasms with non adverse risk cytogenetics

Younger donors better outcomes The impact of donor age in haploidentical transplantation for acute myeloid leukemia study conducted on behalf of geth TC

Next generation sequencing based mutation profile in secondary compared to de novo acute myeloid leukemia patients undergoing allogeneic stem cell transplantation A study from the ALWP EBMT

Outcomes of 544 patients with t 6 9 Acute Myeloid Leukemia undergoing allogeneic stem cell transplantation An EBMT Study on behalf of the acute leukemia working party ALWP and the pediatric diseases working party PDWP

Allogeneic stem cell transplantation with post transplantation cyclophosphamide in patients with acute myeloid leukemia achieving first complete remission after one versus two inductions A study from the ALWP EBMT